Aras’s Significant Growth Investment by GI Partners

On April 15, 2021, IBM announced a definitive agreement to acquire myInvenio, a process mining software company based in Reggio Emilia, Italy. The acquisition will provide organizations with data‑driven software to help them identify the most impactful business processes to automate using AI – including sales, procurement, production and accounting. Financial details were not disclosed. Cravath is representing IBM in connection with the transaction.

On April 15, 2021, Thermo Fisher Scientific Inc. (“Thermo Fisher”), a leader in serving science, and PPD, Inc. (“PPD”), a leading provider of clinical research services to the pharma and biotech industry, announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt. Cravath is representing Thermo Fisher in connection with the transaction.

On April 11, 2021, DiaSorin S.p.A. (“DiaSorin”), a leading global diagnostics company, announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (“Luminex”), a leader in multiplexing technology, for a price of $37.00 per share in an all‑cash transaction corresponding to an enterprise value of approximately $1.8 billion. Cravath is representing DiaSorin in connection with the transaction.

On April 8, 2021, CommScope Holding Company, Inc., a global leader in connectivity solutions for communications networks, announced its plan to spin off its Home Networks business and other initiatives. The separation is intended to be executed through a tax‑free spin‑off to CommScope shareholders to form a new and independent publicly traded company. Cravath is representing CommScope in connection with the transaction.